DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,042 filers reported holding DANAHER CORPORATION in Q3 2023. The put-call ratio across all filers is 0.89 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $139,079,000 | -2.3% | 1,648,054 | -1.0% | 1.29% | -4.2% |
| Q1 2017 | $142,375,000 | +5.5% | 1,664,622 | -4.0% | 1.34% | +5.9% |
| Q4 2016 | $134,918,000 | -5.5% | 1,733,275 | -4.9% | 1.27% | -5.4% |
| Q3 2016 | $142,819,000 | -8.5% | 1,821,908 | +17.9% | 1.34% | -9.8% |
| Q2 2016 | $156,134,000 | +19.4% | 1,545,881 | +12.1% | 1.49% | +46.4% |
| Q1 2016 | $130,773,000 | -1.2% | 1,378,586 | -3.3% | 1.02% | +34.7% |
| Q4 2015 | $132,373,000 | +7.4% | 1,425,206 | -1.5% | 0.75% | +19.1% |
| Q3 2015 | $123,283,000 | -1.1% | 1,446,814 | -0.6% | 0.63% | +6.6% |
| Q2 2015 | $124,628,000 | +1.6% | 1,456,107 | +0.8% | 0.59% | +2.2% |
| Q1 2015 | $122,621,000 | -2.3% | 1,444,302 | -1.4% | 0.58% | -9.2% |
| Q4 2014 | $125,570,000 | +12.6% | 1,465,053 | -0.2% | 0.64% | +8.5% |
| Q3 2014 | $111,486,000 | -4.0% | 1,467,303 | -0.5% | 0.59% | -4.7% |
| Q2 2014 | $116,103,000 | +5.0% | 1,474,696 | +0.0% | 0.62% | +4.7% |
| Q1 2014 | $110,558,000 | -2.7% | 1,474,101 | +0.2% | 0.59% | -6.5% |
| Q4 2013 | $113,582,000 | +10.0% | 1,471,269 | -1.2% | 0.63% | +3.1% |
| Q3 2013 | $103,265,000 | +9.5% | 1,489,687 | +0.0% | 0.61% | +1.0% |
| Q2 2013 | $94,264,000 | – | 1,489,155 | – | 0.61% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
| Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
| Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
| BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
| Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
| Third Point | 2,450,000 | $607,845,000 | 9.22% |
| Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
| Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
| Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
| CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |